WALANT Procedure in Carpal Tunnel Release

Study Overview
=================
Brief Summary
-----------------
The possible benefits expected from the use of the WALANT procedure are a decrease in intraoperative pain at the surgical site, a decrease in hospitalization time, and a decrease in the time required to lift the anesthesia postoperatively. The risks identified are those inherent to each type of anesthesia (WALANT or traditional ALR), as encountered in current practice, and are therefore not specific to the study: risks related to the local anesthetic agent or risks related to the puncture procedure. The main objective is to determine whether the patient's intraoperative pain at the surgical site is less after a WALANT procedure compared to a traditional ALR procedure (axillary or trunk).

Detailed Description
-----------------
Median nerve neurolysis at the carpal tunnel is one of the most performed procedures in the world. The use of loco-regional anesthesia (LRA) is common practice for this surgery, especially since the use of ultrasound guidance, which allows visualization of the nerves and control of the injection of anesthetic products, makes it a safe technique. The nerve blocks most commonly used in hand surgery are axillary blocks and truncal blocks. The choice between these two techniques, which are equivalent in terms of effectiveness and duration of anesthesia, depends in practice on the habits of each practitioner. As the use of a pneumatic tourniquet during the operation is systematic, the axillary block, by anaesthetizing the whole arm, avoids the discomfort described by some patients when using a tourniquet. For others, the discomfort is related to the sensation of a dead arm with a duration of anesthesia of several hours, which the truncular block makes it possible to avoid. Recently, an alternative to traditional LRA by local anesthesia without tourniquet and without sedation (WALANT procedure: Wide Awake Local Anesthesia with No Tourniquet) has been described. Several studies show the efficacy and safety of this procedure, which is already used in current practice. However, to date, there is no comparative study evaluating the effectiveness of the WALANT procedure compared to traditional hand surgery techniques for carpal tunnel, neither published nor in progress. This is the purpose of this study. The WALANT technique, performed under ultrasound, includes two punctures. The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml). The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.

Official Title
-----------------
WALANT (Wide Awake Local Anaesthesia With No Tourniquet) Procedure in Carpal Tunnel Release: a Prospective Randomized Study

Conditions
-----------------
Carpal Tunnel, Median Nerve Neuralgia, Anesthesia, Local

Intervention / Treatment
-----------------
* Procedure: Experimental: WALANT procedure
* Procedure: Active Comparator: Axial ALR
* Procedure: Active Comparator: Truncal ALR


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male or female patient over 18 years of age Membership in a mandatory health insurance plan Patient treated for a first median nerve liberation surgery at the carpal tunnel Patient having been informed of the study and having given informed consent French-speaking patient Exclusion Criteria: Surgical revision Contraindication(s) to loco-regional anesthesia : Coagulation disorder or ongoing anticoagulant therapy Existing peripheral neuropathy Amide-type AL allergy Pregnant or breastfeeding women Inability to undergo the medical follow-up of the study for geographical, social or psychological reasons Patients under legal protection Patients under the influence of drugs that may interfere with the anesthetic techniques under study (cocaine, cannabis, etc. as judged by the investigator) Inclusion of the subject in another research protocol during this study

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Interventional, prospective, therapeutic, comparative, randomized controlled open-label, non-inferiority, single-center, national study.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: WALANT procedure<br>Local anesthesia of the WALANT type | Procedure: Experimental: WALANT procedure<br>* The WALANT technique, performed under ultrasound, includes two punctures. The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml). The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.<br>|
| Active Comparator: Axial ALR<br>Axillary loco-regional anesthesia | Procedure: Active Comparator: Axial ALR<br>* The anesthetic protocol in the axillary block consists of performing a puncture, using a needle (50 mm 22G with a short bevel), under the armpit at the level of the axillary hollow after skin disinfection. This puncture, performed under ultrasound, allows the injection of the local anesthetic around the median, radial, ulnar and musculocutaneous nerves. The volume injected per nerve can vary from 5 to 8 ml depending on the visual appreciation during the injection.<br>|
| Active Comparator: Truncal ALR<br>Truncal loco-regional anesthesia | Procedure: Active Comparator: Truncal ALR<br>* The anesthetic protocol in truncal block consists in injecting the local anesthetic around the median and ulnar nerves by a puncture performed at the elbow or forearm (depending on the practitioner's experience). The volumes injected remain the same and the puncture is also performed under ultrasound guidance. Additional local anesthesia is administered by injecting an additional 5 ml above the wrist flexion line to block the sensory territory of the musculocutaneous nerve.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluation of the patient's pain intraoperatively at the surgical site. | Evaluation of the patient's pain, at the level of the operative site by a visual analog scale from 0 to 10 where 0 equals to No Pain and 10 equals to Extremely severe pain. | Within 24 hours after intervention | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Visual Analog Scale for intraoperative pain at the surgical site | The assessment of pain at the surgical site will be evaluated using a 10-point visual analog scale score from 0 to 10 where 0 equals to No Pain and 10 equals to Extremely severe pain | intraoperative | 
| Satisfaction scores | Satisfaction scores according to the forms provided in the appendices of the anaesthetist and the surgeon | Within 24 hours after intervention | 
| Satisfaction scores | Satisfaction scores according to the forms provided in the appendices of the patient | One day after intervention | 
| Assessment of the patient's overall pain after surgery | Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to No Pain and 10 equals to Extremely severe pain | One day after intervention | 
| Assessment of the patient's overall pain after surgery | Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to No Pain and 10 equals to Extremely severe pain | One month after intervention | 
| Assessment of the patient's overall pain after surgery | Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to No Pain and 10 equals to Extremely severe pain | Three months after intervention | 
| Assessment of the patient's overall pain after surgery | Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to No Pain and 10 equals to Extremely severe pain | Six months after intervention | 
| Evaluation of the return to work after surgery | Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to No disability and 100 equals to Most severe disability and reduced function | Within 24 hours after intervention | 
| Evaluation of the return to work after surgery | Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to No disability and 100 equals to Most severe disability and reduced function | One month after intervention | 
| Evaluation of the return to work after surgery | Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to No disability and 100 equals to Most severe disability and reduced function | Three months after intervention | 
| Evaluation of the return to work after surgery | Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to No disability and 100 equals to Most severe disability and reduced function | Six months after intervention | 
| Evaluation of the quality of life | Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to Poor Health and 100 equals to Good Health | Baseline (Before the anesthesia) | 
| Evaluation of the quality of life | Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to Poor Health and 100 equals to Good Health | One month after intervention | 
| Evaluation of the quality of life | Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to Poor Health and 100 equals to Good Health | Three months after intervention | 
| Evaluation of the quality of life | Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to Poor Health and 100 equals to Good Health | Six months after intervention | 
| Evaluation of the use of analgesics in the postoperative situation | The use of analgesics will be collected until D+1 by defining the following levels of analgesic intake: Level I: use of a paracetamol-type analgesic, up to 4 g/day Level II: use of another type of analgesic (Tramadol or Lamaline®) | One day after intervention | 
| Evaluation of the failure rates of different anesthesia procedures. | The following were considered procedural failures: need for intravenous sedation for all 3 groups, need to inflate the tourniquet (applied as a preventive measure) for the WALANT group only. | Within 24 hours after intervention | 
| Evaluation of the operative time. | Operating time defined as the time from skin incision to skin closure (in minutes) | During surgery | 
| Evaluation of the hospitalization length. | Hospitalization length defined as the time from the patient's admission to the end of the hospitalization (in hours) | Within 24 hours after intervention | 
| Evaluation of the time to release of anesthesia. | Time to release of anesthesia defined as the time from the placement of anesthesia to the release of motor (ability to clench/unclench the hand) and sensory (disappearance of tingling) anesthesia | Within 24 hours after intervention | 
| Evaluation of the safety of different types of anesthesia. | Collection of postoperative adverse events. | One month after intervention |